Of note, some relevant differences in terms of settings and patient characteristics should be underlined, as the previous study was conducted in Uganda (where there is a high burden of malnutrition and infectious diseases) and all patients were on insulin therapy using MDI or Mixtard without access to advanced devices to deliver insulin. Here, INS is linked to infectious disease.